Helpline 07939 046 030

Callum Axford’s Story

09 March 2020

The National Diversity Awards

This year Callum has been selected for the Positive Role Model (Disability) award at the National Diversity Awards. Callum is truly an NF warrior who keeps positive and spreads joy to others. 

To read Callum's full story check out the rest of the article below! 

You can vote for Callum in this years awards by clicking on the 'Vote Now' button.

Callum Axford's Story 

At my 20 week scan we found out that Callum had Congenital Diaphragmatic Hernia (CDH).  That meant Callum had a hole in his diaphragm, so his stomach contents had moved into his chest, preventing his left lung from growing, and pushing his heart into the right lung.  We were transferred to Kings College Hospital, and a termination was suggested as CDH is a very serious condition, and 50% of babies do not survive.  We decided to start the fight for Callum to survive.

I had to have full bed rest, steroid injections, and amniotic fluid drained from my stomach as Callum was unable to swallow it.  Due to complications with my pregnancy I was admitted into Kings College Hospital at 29 weeks.  Callum was born prematurely at 33 weeks.  As soon as he was born he was paralyzed, sedated, put on life support, and taken to Neonatal Intensive Care.  Hours later I saw my baby boy for the very first time, in an incubator, full of wires and tubes breathing for him.

Callum had his first operation at 3 days old, in which they brought his stomach contents back through the hole and used pig skin to fill the hole.  Callum remained in Kings College Hospital NICU for 8 months, having more operations, being pumped with so many medicines, blood transfusions, and needles everywhere even in his head.  I held him, covered in tubes, for the first time when he was 4 weeks old.  We have lost count the amount of times we were told Callum may not survive, numerous times we would be asked to leave the room, not knowing if when we came back our child would be alive.

When Callum finally came home, he was on oxygen 24/7 and had a gastrostomy feeding tube.  At this point Callum had been diagnosed with CDH (repaired), Pulmonary Hypoplasia, Chronic Lung Disease, Oral Aversion, Food Aversion, and Development Delay.

Callum at Birth

Over quite a few years we progressed from full tube feeding, to oral syringe feeding, to blended food, and to date Callum no longer has his tube!

He eats mashed up food and actually loves to be around food now, which is something I never thought would happen.

However, as time passed, we knew as parents something wasn’t right with Callum's development, and it wasn't just because of such a long time in NICU and being on life support.  Callum started sitting at about 2 and a half, he started walking un-aided at 4 years old, but he has balance and co-ordination problems, and cannot walk up and down steps, on uneven ground etc without support.  Callum also had unexplained light brown marks on his body (which we now know as Cafe Au Laits) and was always scratching.  Unfortunately, our local Child Development Doctor at the time was very unsupportive, however, we did not give up.  Finally, when Callum was 6 he was referred to GOSH, and there he had an MRI under general anaesthetic.

I will never forget that moment when Carl and I went back to GOSH, without Callum, to hear the results of his MRI.  The Consultant told us that Callum has Cerebral Palsy.  I actually felt relief at hearing this diagnosis.  Finally, what we had thought for ages was being confirmed, and now with this official diagnosis we could get Callum the help and support he so desperately needed, and deserved.  The Consultant said he was actually surprised to see the extent of the brain damage, after meeting Callum and seeing how well he has done.  However, he then said he was very sorry to tell us that the scan showed another condition, Neurofibromatosis Type 1 (NF1), including Optic Tumours.  That feeling of being at my 20 week scan came over me, as I was being told about another serious condition I had never heard of, although I later found out that like CDH, NF1 is also as common as Cystic Fybrosis, but yet again with poor awareness and research it is so unknown.

Callum at 6 months

So, we now know Callum has Congenital Diaphragmatic Hernia (repaired), Chronic Lung Disease, Pulmonary Hypoplasia, Cerebral Palsy and Neurofibromatosis Type 1 (NF1).  We now have more hospital appointments than ever before but are so thankful that Callum is seen by all the necessary people, including the NF1 Clinic at Guys Hospital.  As far as we know he is the only person who has all these conditions.

Callum has made remarkable progress, he is a very determined happy little boy, who never gives up.  Callum currently has leg splints and has had leg serial casting.  He relies on help when walking outside of his home, and his little sister Sophie (age 5) is a fantastic support for him.  He has a wheelchair for long distance, and a supporting chair at school, where he has an EHCP and 1 to 1 support.  Callum is a clever boy, but he requires certain techniques in order to learn, and uses a computer more as he struggles with writing.  Callum has home oxygen, but no longer requires it 24/7.  He has inhalers and nebulisers and is getting to know himself when these are needed.

Callum has always had difficulties sleeping.  He cannot close his eyes on demand, so they only close when he is literally so tired, they close automatically.  He has Melatonin every night, which is taken by many people who have NF1.  Soon he will be seen at the Evelina Sleep Clinic. 

Callum is also in the process of having tests under the Endocrine team at the Evelina, as his bone age is that of 5 and a half years old.  No one knows why he isn't growing at a good rate; which Callum does find a little frustrating as he longs to be taller like his friends.

Callum at BBC Children in need

The past 9 years have been tough, there have been many times when I have sobbed into my pillow, screamed why? and thought to myself I can't keep fighting for everything, but then I get myself together again, and think to myself if my little boy can be super strong with the best attitude to life, them so can I.  There is no cure for Callum, but to get the diagnoses is half the battle, and once you have them and you start to tick the boxes, and realise why he has these marks, why he does the things he does, it all starts to make sense, and then you can move forward.  We have never given up, no one knew if Callum would walk, talk, eat, go to mainstream school, and although there are challenges with all these he is doing it! 

"We have never given up, no one knew if Callum would walk, talk, eat, go to mainstream school, and although there are challenges with all these he is doing it! "

– Callum's Mum Faye

Of course, as Callum's parents we think he is amazing.  He has gone through more in 9 years, than many will ever go through in their lifetime.  However, we do receive so many fantastic comments from everyone who meets Callum.  He does light up a room with his smile, laugh and funny ways, and this month the panel at the Pride of Essex Awards thought so too, as they presented him with Child of Courage Award 2019!

A couple of years ago Callum became a Rays of Sunshine Wish Child.  From this wish Callum has had just the most amazing time, and is now an ambassador for the charity, and a member of their choir.  From going to Disneyland Paris, to singing with Alfie Boe at The Royal Albert Hall, to being invited to the Arsenal Player Ozil's house!  We are so thankful to them for giving us so many amazing memories, to cherish forever.

"We are so thankful to them for giving us so many amazing memories, to cherish forever."

– Faye

You may have seen Callum earlier this month when he took part in BBC Children in Need Bargain Hunt with Sooty and Debbie McGee, and then later that evening was interviewed live by BBC London for Children in Need, to talk about how their donations help fund Rays of Sunshine Hospital Activity Days across the country.  Callum was fantastic on TV, and a lot less nervous than me!

NF1 is such a complex serious condition, but it is not given enough awareness and funding into research.  A benign tumour is not fine!  With all Callum's conditions he truly is a little warrior.  He faces battles daily, and will never live a 'normal' life, but I know his personality alone will see him through and I know he will never give up and think poor me. 

"NF1 is such a complex serious condition, but it is not given enough awareness and funding into research. A benign tumour is not fine! "

– Faye

Filter News

Filter by Date
Category
Reset

Luke’s Story

Read More

Charlotte’s Story

Read More

Eden P Study

Currently pregnant? Please consider taking part in the Eden P study

Read More

Jen’s NF1 story

Jen praises the great support received since her NF1 diagnosis, allowing her to thrive & achieve a 1st class degree.

Read More

Eden P for healthcare professionals

Healthcare professionals, who provide support to expectant parents with NF1 are invited to take part in the Eden P study

Read More

Nicole’s story

Nicole has NF2, she describes the preparations and the absolute joyful experience of the birth of her son Lewis

Read More

Johnathan’s story

Johnathon's family are spreading awareness of the importance of attending health checks and advocating for vulnerable people

Read More

CAR Research - exploring family planning decisions

Research Advisors required to help explore what influences decisions about having children and what support would be helpful

Read More

Corporate Fundraising 2024

Find out some of the different ways your company can support Nerve Tumours UK

Read More

Masterclasses in NF: Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome - Prof. Dr. Katharina Wimmer

Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome

Prof. Dr. Katharina Wimmer, Medical University of Innsbruck

Masterclasses in NF: Rare NF1-Associated Tumors in Adults - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: Rare NF1-Associated Tumors in Adults

Eric Legius, MD, PhD, University Hospital Leuven

Prof. Ellen Denayer, University Hospital Leuven

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis - Simon Freeman

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis

Simon Freeman, MPhil FRCS, Manchester Royal Infirmary and Salford Royal Hospital

Masterclasses in NF: NF1 Dermatological Manifestations - Pierre Wolkenstein, Laura Fertitta & Sirkku Peltonen

Masterclasses in NF: NF1 Dermatological Manifestations

Pierre Wolkenstein, MD, PhD, Hopital Henri-Mondor, Paris, France

Laura Fertitta, MD, Hôpital Universitaire Henri Mondor

Sirkku Peltonen, MD, PhD, University of Gothenberg, Sweden

Masterclasses in NF: Breast Cancer in NF1 - Gareth Evans

Masterclasses in NF: Breast Cancer in NF1

Gareth Evans, MD, University of Manchester, UK

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis - David Pang

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis

David Pang, MD, ChB. Guys and St Thomas' Hospital NHS Trust, London

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches - Said Farschtschi

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches

Said Farschtschi, MD, University Medical Center, Hamburg-Eppendorf, Germany

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis

Eric Legius, MD, PHD, University Hospital of Leuven, Belgium

Prof. Ellen Denayer, University Hospital of Leuven, Belgium

NF2 Working Together: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 2: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 1: from a tentative diagnosis and beyond

Understanding  the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

Masterclasses in NF: Surgery in NF2 - Michel Kalamarides & Andrew King

Masterclasses in NF: Surgery in NF2

Michel Kalamarides, MD, PhD, Hôpital Pitié-Salpêtrière, Paris, France

Prof Andrew King, MBBS FRCS FRCS(SN), Salford Royal Hospital, Manchester, United Kingdom. Member of the MAB of Nerve Tumours UK

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches - Shruti Garg, Andre Rietman

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches

Dr Shruti Garg, MBBS, MRCPsych, MMedSci, PhD, Royal Manchester Children’s Hospital, United Kingdom. Member of the MAB of Nerve Tumours UK

Andre Rietman, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis - Susie Henley, Thomas Pletschko & Verena Rosenmayr

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis

Susie Henley, DClinPsy, PhD, Guy’s and St Thomas’ NHS Foundation Trust, London UK

Thomas Pletschko, PhD, Medical University of Vienna, Austria

Verena Rosenmayr, Clinical Psychologist, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Pediatric Management - Rianne Oostenbrink

Masterclasses in NF: NF1 Pediatric Management

Rianne Oostenbrink, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond - Amedeo Azizi

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond

Amedeo Azizi, MD, PhD, Head of the Paediatric Neurofibromatosis Program and Paediatric Neuro-Oncology Program, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Orthopedic Manifestations - Eric Legius and Christophe Glorion

Masterclasses in NF: NF1 Orthopedic Manifestations

Eric Legius, MD, PhD. Head of Clinical Genetics Department of the University Hospital Leuven, Belgium

Christophe Glorion, MD, PhD, Department of Paediatric Orthopedic and Traumatologic Surgery, Hopital Necker-Enfants Malades, Paris, France. 

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours - Rosalie Ferner and Viktor-Felix Mautner

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK

Viktor-Felix Mautner, MD, PhD. University Medical Centre in Hamburg-Eppendorf, Germany. Head of NF Outpatient Department

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas - Pierre Wolkenstein and Sirkku Peltonen

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas

Pierre Wolkenstein, MD, PhD. Hopital Henri-Mondor, Paris, France. Head of the Department of Dermatology

Sirkku Peltonen MD, PhD. University of Gothenberg, Sweden. Professor of Dermatology

INFER (International NF Educational Resources) is a series of online educational lectures for medical professionals by leading neurofibromatosis experts. The Masterclasses take place online approximately once a month, each on a different topic, and include real-time interaction between the expert presenter and the participants. The presentations are conducted in English, with real-time audio interpretation available in 6 additional languages: French, German, Italian, Portuguese, Russian, and Spanish. A recording of each INFER masterclass is then be made available online in each language for those who could not attend an event. INFER is an initiative of Children’s Tumor Foundation Europe, supported by an educational grant from AstraZeneca. https://ctfeurope.org/research/masterclasses-in-nf

BPNA Keynote Lecture - Prof Rosalie Ferner - Neurofibromatosis 1 in the 21st Century

‘Neurofibromatosis 1 in the 21st Century’

Keynote Lecture at the 48th British Paediatric Neurology Association Annual Scientific Meeting on 21st January 2022

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK